Showing results (1-10 of 5,467) with videos related to
Sort By:
Pageof 547
Frontiers of Medicine|December 18, 2021
CAR T-cell immunotherapy: a powerful weapon for fighting hematological B-cell malignanciesJian-Qing Mi, Jie Xu, Jianfeng Zhou, et al.Cytotherapy|April 9, 2013
Innovation and opportunity for chimeric antigen receptor targeted T cellsJ Joseph Melenhorst, Bruce L LevineMolecular Endocrinology (Baltimore, Md.)|November 29, 2002
Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3Ling Zhao, J Joseph Melenhorst, Lothar HennighausenInternational Journal of Hematology|June 29, 2020
Next-generation CAR T cells to overcome current drawbacksStefan Lundh, Sayantan Maji, J Joseph MelenhorstNature Cancer|September 6, 2021
Engineering enhanced CAR T-cells for improved cancer therapyMichael C Milone, Jie Xu, Sai-Juan Chen, et al.Seminars in Cancer Biology|December 24, 2019
Mechanisms of resistance to CAR T cell therapiesNathan Singh, Elena Orlando, Jun Xu, et al.Cytotherapy|April 15, 2018
Toward precision manufacturing of immunogene T-cell therapiesJun Xu, J Joseph Melenhorst, Joseph A FraiettaCancers|February 13, 2025
Leveraging Vector-Based Gene Disruptions to Enhance CAR T-Cell EffectivenessBeatriz C Oliveira, Saaurav Bari, J Joseph MelenhorstGene Expression Patterns : GEP|June 9, 2004
The proliferation associated nuclear element (PANE1) is conserved between mammals and fish and preferentially expressed in activated lymphoid cellsBrian Bierie, Micah Edwin, J Joseph Melenhorst, et al.Current Hematologic Malignancy Reports|January 15, 2021
High-Dimensional Immune Monitoring for Chimeric Antigen Receptor T Cell TherapiesSujata Sharma, David Quinn, J Joseph Melenhorst, et al.Pageof 547